In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kraska, Audrey ^a,b,c   Santin, Mathieu D ^a,b   Dorieux, Olène ^a,b   Joseph Mathurin, Nelly ^a,b   Bourrin, Emmanuel ^a,b,c   Petit, Fanny ^a,b   Jan, Caroline ^a,b   Chaigneau, Marion ^a,b   Hantraye, Philippe ^a,b   Lestage, Pierre ^c   Dhenain, Marc ^a,b  

^a CNRS   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN DAMAGE; BRAIN REGION; BRAIN SIZE; CELL LOSS; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE SEVERITY; GLIOSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAGNETIC FIELD; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RAT; SEPTUM NUCLEUS; WHITE MATTER;

ANIMALS; BRAIN; DEMENTIA; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN;

ANIMALIA; RATTUS;

EID: 84866717339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046196     Document Type: Article

References (56)

1. Frölich L, Hoyer S, Blum-Degen D, Bernstein HG, Engelsberger S, et al. (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105: 423-438.
2. Hoyer S, (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105: 415-422.
3. de la Monte SM, Wands JR, (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7: 45-61.
4. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, et al. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7: 63-80.
5. Lenzen S, (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51: 216-226.
6. Hoyer S, Muller D, Plaschke K, (1994) Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism. J Neural Transm Suppl 44: 259-268.
7. Lannert H, Hoyer S, (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112: 1199-1208.
8. Plaschke K, Hoyer S, (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11: 477-483.
9. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, et al. (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Res Rev 10: 264-273.
10. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, et al. (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9: 13-33.
11. Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, et al. (2010) Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Deteriorates Alzheimer-like Changes in Tg2576 AbetaPP-Overexpressing Mice. J Alzheimers Dis 19: 691-704.
12. Salkovic-Petrisic M, Hoyer S, (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl:72: 217-233.
13. Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL, (2009) Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor. Eur J Pharmacol 620: 49-56.
14. Sapcanin A, Sofic E, Tahirovic I, Salkovic-Petrisic M, Hoyer S, et al. (2008) Antioxidant capacity in rat brain after ICV treatment with streptozotocin and alloxan- a preliminary study. Neurotoxicity Research 13: 97-104.
15. Sharma M, Gupta YK, (2001) Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 68: 1021-1029.
16. Sultana R, Mecocci P, Mangialasche F, Cecchetti R, Baglioni M, et al. (2011) Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. J Alzheimers Dis 24: 77-84.
17. de la Monte SM, Wands JR, (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis 9: 167-181.
18. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL, (2010) Ageing and neurodegenerative diseases. Ageing Res Rev 9 Suppl 1: S36-46.
19. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, et al. (1996) Oxidative damage in Alzheimer's. Nature 382: 120-121.
20. Agrawal R, Tyagi E, Shukla R, Nath C, (2011) Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur Neuropsychopharmacol 21: 261-273.
21. Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M, (2007) Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 52: 836-843.
22. Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, et al. (2011) Neuroprotective Effect of Cyclooxygenase Inhibitors in ICV-STZ Induced Sporadic Alzheimer's Disease in Rats. J Mol Neurosci 46: 223-235.
23. Sharma N, Deshmukh R, Bedi KL, (2011) SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 96: 386-394.
24. Isik AT, Celik T, Ulusoy G, Ongoru O, Elibol B, et al. (2009) Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model. Age (Dordr) 31: 39-49.
25. Javed H, Khan MM, Khan A, Vaibhav K, Ahmad A, et al. (2011) S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 1389: 133-142.
26. Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, et al. (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 1281: 117-127.
27. Saxena G, Singh SP, Agrawal R, Nath C, (2008) Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol 581: 283-289.
28. Sonkusare S, Srinivasan K, Kaul C, Ramarao P, (2005) Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77: 1-14.
29. Pathan AR, Viswanad B, Sonkusare SK, Ramarao P, (2006) Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci 79: 2209-2216.
30. Tramontina AC, Wartchow KM, Rodrigues L, Biasibetti R, Quincozes-Santos A, et al. (2011) The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats. J Neural Transm 118: 1641-9.
31. Sharma B, Singh N, Singh M, (2008) Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease type by pitavastatin and donepezil. J Psychopharmacol 22: 162-171.
32. Prakash AK, Kumar A, (2009) Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats. J Pharm Pharmacol 61: 1665-1672.
33. Sharma B, Singh N, Singh M, Jaggi AS, (2008) Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav 89: 535-545.
34. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S, (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101: 757-770.
35. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P, (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96: 1005-1015.
36. Salkovic-Petrisic M, Osmanovic-Barilar J, Bruckner MK, Hoyer S, Arendt T, et al. (2011) Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm 118: 765-772.
37. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates; Press A, editor: Harcourt Brace Jovanovich.
38. Diguet E, Petit F, Escartin C, Cambon K, Bizat N, et al. (2009) Normal aging modulates the neurotoxicity of mutant huntingtin. PLoS One 4: e4637.
39. Eriksson SH, Free SL, Thom M, Symms MR, Martinian L, et al. (2009) Quantitative grey matter histological measures do not correlate with grey matter probability values from in vivo MRI in the temporal lobe. J Neurosci Methods 181: 111-118.
40. McGeer PL, Kamo H, Harrop R, McGeer EG, Martin WR, et al. (1986) Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology 36: 1569-1574.
41. Shoham S, Bejar C, Kovalev E, Weinstock M, (2003) Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184: 1043-1052.
42. Frederiksen KS, Garde E, Skimminge A, Ryberg C, Rostrup E, et al. (2011) Corpus callosum atrophy in patients with mild Alzheimer's disease. Neurodegener Dis 8: 476-482.
43. Janowsky JS, Kaye JA, Carper RA, (1996) Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. J Am Geriatr Soc 44: 798-803.
44. Terwel D, Prickaerts J, Meng F, Jolles J, (1995) Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur J Pharmacol 287: 65-71.
45. Woolf NJ, (1991) Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37: 475-524.
46. Fitz NF, Gibbs RB, Johnson DA, (2006) Aversive stimulus attenuates impairment of acquisition in a delayed match to position T-maze task caused by a selective lesion of septo-hippocampal cholinergic projections. Brain Res Bull 69: 660-665.
47. Niewiadomska G, Baksalerska-Pazera M, Riedel G, (2009) The septo-hippocampal system, learning and recovery of function. Prog Neuropsychopharmacol Biol Psych 33: 791-805.
48. Kesner RP, (1988) Reevaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiol Aging 9: 609-616.
49. Pinton S, da Rocha JT, Gai BM, Nogueira CW, (2011) Sporadic dementia of Alzheimer's type induced by streptozotocin promotes anxiogenic behavior in mice. Behav Brain Res 223: 1-6.
50. Wiley RG, Oeltmann TN, Lappi DA, (1991) Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res 562: 149-153.
51. Wyss-Coray T, Mucke L, (2002) Inflammation in neurodegenerative disease- A double-edged sword. Neuron 35: 419-432.
52. Coffey PJ, Perry VH, Rawlins JN, (1990) An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration. Neuroscience 35: 121-132.
53. Kirby BP, Rawlins JN, (2003) The role of the septo-hippocampal cholinergic projection in T-maze rewarded alternation. Behav Brain Res 143: 41-48.
54. Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, et al. (2006) Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 171: 9-16.
55. Szkudelski T, (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 537-546.
56. Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, et al. (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain-an immunohistochemical study. J Chem Neuroanat 28: 117-136.